$TRXA
T-REX Acquisition Corp.

2023 Q2 Form 10-Q Financial Statement

#000147793223003980 Filed on May 25, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $55.64K $19.94K
YoY Change 56.29% -24.18%
Cost Of Revenue $572.2K $34.90K
YoY Change 24779.13% -11.99%
Gross Profit -$516.6K -$14.96K
YoY Change -1651.29% 12.03%
Gross Profit Margin -928.43% -74.98%
Selling, General & Admin $1.323M $243.7K
YoY Change 23.27% 204.74%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $434.7K $19.19K
YoY Change 1721.07%
% of Gross Profit
Operating Expenses $1.323M $243.7K
YoY Change 337.36% 204.73%
Operating Profit -$1.840M -$258.6K
YoY Change 583.32% 177.16%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.840M -$258.6K
YoY Change 540.99% 177.16%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.840M -$258.6K
YoY Change 540.99% 177.16%
Net Earnings / Revenue -3306.56% -1296.75%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.10 -$0.01
COMMON SHARES
Basic Shares Outstanding 18.22M shares 19.84M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.91K $0.00
YoY Change 156.55% -100.0%
Cash & Equivalents $23.91K $0.00
Short-Term Investments $0.00
Other Short-Term Assets $161.6K $104.5K
YoY Change 237.76%
Inventory
Prepaid Expenses $161.5K $104.5K
Receivables
Other Receivables
Total Short-Term Assets $185.5K $104.5K
YoY Change 224.51% 125.54%
LONG-TERM ASSETS
Property, Plant & Equipment $14.95K $454.3K
YoY Change -96.45% 3.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change -100.0% -100.0%
Other Assets $152.2K $228.3K
YoY Change -62.77%
Total Long-Term Assets $167.2K $682.6K
YoY Change -80.12% 52.32%
TOTAL ASSETS
Total Short-Term Assets $185.5K $104.5K
Total Long-Term Assets $167.2K $682.6K
Total Assets $352.6K $787.1K
YoY Change -60.74% 59.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $63.71K $71.50K
YoY Change 236.2% 211.28%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $69.53K $10.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $629.0K $397.6K
YoY Change 352.69% 650.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $629.0K $397.6K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $629.0K $397.6K
YoY Change 352.69% 650.62%
SHAREHOLDERS EQUITY
Retained Earnings -$6.001M -$5.426M
YoY Change 44.22% 40.08%
Common Stock $1.822K $1.821K
YoY Change -90.69% -88.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$276.4K $389.5K
YoY Change
Total Liabilities & Shareholders Equity $352.6K $787.1K
YoY Change -60.74% 59.18%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$1.840M -$258.6K
YoY Change 540.99% 177.16%
Depreciation, Depletion And Amortization $434.7K $19.19K
YoY Change 1721.07%
Cash From Operating Activities $231.8K -$235.2K
YoY Change -278.28% 134.74%
INVESTING ACTIVITIES
Capital Expenditures -$2.000K -$3.740K
YoY Change -74.87% -95.39%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $2.000K $3.740K
YoY Change -125.13% -104.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -210.0K 206.1K
YoY Change -277.89% 3.05%
NET CHANGE
Cash From Operating Activities 231.8K -235.2K
Cash From Investing Activities 2.000K 3.740K
Cash From Financing Activities -210.0K 206.1K
Net Change In Cash 23.80K -25.32K
YoY Change -219.42% -235.55%
FREE CASH FLOW
Cash From Operating Activities $231.8K -$235.2K
Capital Expenditures -$2.000K -$3.740K
Free Cash Flow $233.8K -$231.4K
YoY Change -291.55% 1115.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
71502 usd
CY2023Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
326100 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
397612 usd
CY2023Q1 us-gaap Liabilities
Liabilities
397612 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19573952 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1821 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5813782 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4160757 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
759202 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
898156 usd
CY2022Q1 us-gaap Revenues
Revenues
26305 usd
us-gaap Revenues
Revenues
57731 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
34899 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
389462 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
787074 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001437750
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1957 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19573952 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18223952 shares
CY2014Q2 trxa Exercise Price
ExercisePrice
0.80
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-266766
dei Entity Registrant Name
EntityRegistrantName
T-REX Acquisition Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1754034
dei Entity Address Address Line1
EntityAddressAddressLine1
7301 NW 4th Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 102
dei Entity Address City Or Town
EntityAddressCityOrTown
Plantation
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33317
dei City Area Code
CityAreaCode
954
dei Local Phone Number
LocalPhoneNumber
742-3001
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18223952 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
104500 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
104500 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
454254 usd
CY2023Q1 trxa Crypto Currency Held Non Current
CryptoCurrencyHeldNonCurrent
0 usd
CY2022Q2 trxa Crypto Currency Held Non Current
CryptoCurrencyHeldNonCurrent
9211 usd
CY2022Q2 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
408804 usd
CY2023Q1 trxa Facility Deposit Noncurrent
FacilityDepositNoncurrent
0 usd
CY2022Q2 trxa Facility Deposit Noncurrent
FacilityDepositNoncurrent
10570 usd
CY2023Q1 us-gaap Assets
Assets
787074 usd
CY2023Q1 us-gaap Bank Overdrafts
BankOverdrafts
10 usd
CY2022Q2 us-gaap Bank Overdrafts
BankOverdrafts
0 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
120000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
138954 usd
CY2022Q2 us-gaap Liabilities
Liabilities
138954 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4918002 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5426142 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18223952 shares
CY2023Q1 us-gaap Revenues
Revenues
19944 usd
us-gaap Revenues
Revenues
26305 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39654 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
117584 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39654 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
-14955 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
-13349 usd
us-gaap Gross Profit
GrossProfit
-59853 usd
us-gaap Gross Profit
GrossProfit
-13349 usd
CY2023Q1 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
13032 usd
CY2022Q1 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
637 usd
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
17835 usd
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
4433 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
14002 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
41000 usd
us-gaap Professional Fees
ProfessionalFees
63686 usd
us-gaap Professional Fees
ProfessionalFees
113330 usd
CY2023Q1 us-gaap Management Fee Expense
ManagementFeeExpense
58500 usd
CY2022Q1 us-gaap Management Fee Expense
ManagementFeeExpense
30000 usd
us-gaap Management Fee Expense
ManagementFeeExpense
317500 usd
us-gaap Management Fee Expense
ManagementFeeExpense
90000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
112500 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
747857 usd
us-gaap Share Based Compensation
ShareBasedCompensation
770850 usd
CY2023Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
45634 usd
CY2022Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
8326 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
58654 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
15212 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
243668 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
79963 usd
us-gaap Operating Expenses
OperatingExpenses
1205532 usd
us-gaap Operating Expenses
OperatingExpenses
993825 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-258623 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-93312 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1265385 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1007174 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-258623 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-93312 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1265385 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1007174 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-258623 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-93312 usd
us-gaap Net Income Loss
NetIncomeLoss
-1265385 usd
us-gaap Net Income Loss
NetIncomeLoss
-1007174 usd
CY2023Q1 trxa Net Loss Per Common Share Basic Diluted
NetLossPerCommonShareBasicDiluted
-0.01
CY2022Q1 trxa Net Loss Per Common Share Basic Diluted
NetLossPerCommonShareBasicDiluted
-0.01
trxa Net Loss Per Common Share Basic Diluted
NetLossPerCommonShareBasicDiluted
-0.06
trxa Net Loss Per Common Share Basic Diluted
NetLossPerCommonShareBasicDiluted
-0.06
CY2023Q1 trxa Weighted Average Number Of Common Shares Outstanding Basic Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicDiluted
18906544 shares
CY2022Q1 trxa Weighted Average Number Of Common Shares Outstanding Basic Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicDiluted
16169106 shares
trxa Weighted Average Number Of Common Shares Outstanding Basic Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicDiluted
19495849 shares
trxa Weighted Average Number Of Common Shares Outstanding Basic Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicDiluted
15851171 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-46124 usd
CY2022 trxa Shares Issued For Related Party Debt Conversion Amount
SharesIssuedForRelatedPartyDebtConversionAmount
45000 usd
CY2022 trxa Share Based Expense For Warrants Issued
ShareBasedExpenseForWarrantsIssued
770850 usd
CY2022 trxa Shares Issued For Subscriptions Amount
SharesIssuedForSubscriptionsAmount
560875 usd
CY2022 trxa Shares Issued For Services Amount
SharesIssuedForServicesAmount
604749 usd
CY2022 trxa Shares Issued For Debt Conversion Amount
SharesIssuedForDebtConversionAmount
118050 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-1294198 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
759202 usd
CY2022Q3 trxa Shares Issued For Cash Amount
SharesIssuedForCashAmount
200000 usd
CY2022Q3 trxa Share Based Expense For Warrants Issued
ShareBasedExpenseForWarrantsIssued
483145 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-823949 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
618398 usd
CY2022Q4 trxa Shares Issued For Cash
SharesIssuedForCash
100000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-182813 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
535585 usd
CY2023Q1 trxa Shares Surrendered Amount
SharesSurrenderedAmount
0 usd
CY2023Q1 trxa Shares Issued For Services Amount
SharesIssuedForServicesAmount
112500 usd
CY2023Q1 trxa Shares Issued For Cash Amount
SharesIssuedForCashAmount
0 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-258623 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
389462 usd
us-gaap Profit Loss
ProfitLoss
1265385 usd
us-gaap Profit Loss
ProfitLoss
1007174 usd
us-gaap Other Expenses
OtherExpenses
595645 usd
us-gaap Other Expenses
OtherExpenses
770850 usd
us-gaap Depreciation
Depreciation
55379 usd
us-gaap Depreciation
Depreciation
7956 usd
trxa Increase Decrease In Crypto Currency Held
IncreaseDecreaseInCryptoCurrencyHeld
-9211 usd
trxa Increase Decrease In Crypto Currency Held
IncreaseDecreaseInCryptoCurrencyHeld
26305 usd
trxa Increase Decrease In Change In Facility Deposit
IncreaseDecreaseInChangeInFacilityDeposit
10570 usd
trxa Increase Decrease In Change In Facility Deposit
IncreaseDecreaseInChangeInFacilityDeposit
-10570 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-123818 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
148049 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
52548 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
21848 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-418214 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-95346 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
445500 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-445500 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
206100 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
trxa Proceeds From Subscriptions Receivable
ProceedsFromSubscriptionsReceivable
300000 usd
trxa Proceeds From Subscriptions Receivable
ProceedsFromSubscriptionsReceivable
560875 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
506100 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
560875 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-114 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
20029 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20029 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
trxa Share Based Compensation And Warrants Vested
ShareBasedCompensationAndWarrantsVested
483145 usd
trxa Share Based Compensation And Warrants Vested
ShareBasedCompensationAndWarrantsVested
150850 usd
trxa Share Based Compensation And Shares Vested
ShareBasedCompensationAndSharesVested
264712 usd
trxa Share Based Compensation And Shares Vested
ShareBasedCompensationAndSharesVested
620000 usd
CY2021Q3 us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
885000 usd
us-gaap Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
1 pure
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates.</p>
CY2023Q1 us-gaap Depreciation Expense On Reclassified Assets
DepreciationExpenseOnReclassifiedAssets
19307 usd
us-gaap Depreciation Expense On Reclassified Assets
DepreciationExpenseOnReclassifiedAssets
55498 usd
CY2022Q1 us-gaap Depreciation Expense On Reclassified Assets
DepreciationExpenseOnReclassifiedAssets
7956 usd
us-gaap Depreciation Expense On Reclassified Assets
DepreciationExpenseOnReclassifiedAssets
7956 usd
CY2023Q1 trxa Operating Loss Carryforward
OperatingLossCarryforward
1849716 usd
CY2023Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
388440 usd
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.21 pure
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
388440 usd
CY2022Q1 trxa Deferred Tax Asset
DeferredTaxAsset
388440 usd
CY2022Q2 trxa Deferred Tax Asset
DeferredTaxAsset
873759 usd
CY2022Q1 trxa Valuation Allowance
ValuationAllowance
388440 usd
CY2022Q2 trxa Valuation Allowance
ValuationAllowance
873759 usd
CY2022Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023Q1 trxa Shares Issued Upon Conversion Of Warrant Shares
SharesIssuedUponConversionOfWarrantShares
3285332 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 trxa Common Stock Par Or Stated Value Per Share Adjustment
CommonStockParOrStatedValuePerShareAdjustment
0.0001
trxa Incurred Net Loss
IncurredNetLoss
1265385 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5426142 usd
CY2023Q1 trxa Working Capital Deficit
WorkingCapitalDeficit
-293112 usd
CY2022 trxa Shares Issued For Related Party Payables Conversion Shares
SharesIssuedForRelatedPartyPayablesConversionShares
1182009 shares
CY2022 trxa Shares Issued For Related Party Payables Conversion Amount
SharesIssuedForRelatedPartyPayablesConversionAmount
118050 usd
CY2023Q1 us-gaap Due From Other Related Parties
DueFromOtherRelatedParties
245900 usd
us-gaap Results Of Operations Income Tax Expense
ResultsOfOperationsIncomeTaxExpense
304426 usd
CY2023Q1 trxa Prepaid Amount Current
PrepaidAmountCurrent
76106 usd
CY2023Q1 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
228320 usd
CY2022 us-gaap Results Of Operations Income Tax Expense
ResultsOfOperationsIncomeTaxExpense
456638 usd
CY2022Q2 trxa Prepaid Amount Current
PrepaidAmountCurrent
47834 usd
CY2022Q2 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
408804 usd
CY2022 trxa Shares Issued For Related Party Payables Conversion Amount
SharesIssuedForRelatedPartyPayablesConversionAmount
118050 usd
CY2022Q2 trxa Issued Of Aggregate Common Stock Shares
IssuedOfAggregateCommonStockShares
6530267 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 trxa Warrants Issued
WarrantsIssued
747837 shares
CY2023Q1 trxa Issued Of Aggregate Common Stock Shares
IssuedOfAggregateCommonStockShares
2437500 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
250000 shares
CY2014Q2 trxa Description Of Warrants Exercise
DescriptionOfWarrantsExercise
Each Unit shall consist of (a) one (1) share of common stock and (b) a combination of series A warrants (which may be exercised within three (3) years) and series B warrants exercised within five (5) years of the consummation of a merger
CY2022Q3 trxa Warrants Issued
WarrantsIssued
747837 shares
us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
250000 shares
trxa Exercise Price
ExercisePrice
1.50
trxa Crypto Currency Held Current Beginning
CryptoCurrencyHeldCurrentBeginning
9211 usd
CY2022 trxa Crypto Currency Held Current Beginning
CryptoCurrencyHeldCurrentBeginning
0 usd
us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
57731 usd
CY2022 us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
61906 usd
us-gaap Unrecognized Tax Benefits Increases Resulting From Acquisition
UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
66942 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Acquisition
UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition
61906 usd
trxa Bitcoin Used For Operational Expenses
BitcoinUsedForOperationalExpenses
66942 usd
CY2022 trxa Bitcoin Used For Operational Expenses
BitcoinUsedForOperationalExpenses
52695 usd
trxa Crypto Currency Held Current Ending
CryptoCurrencyHeldCurrentEnding
0 usd
CY2022 trxa Crypto Currency Held Current Ending
CryptoCurrencyHeldCurrentEnding
9211 usd

Files In Submission

Name View Source Status
0001477932-23-003980-index-headers.html Edgar Link pending
0001477932-23-003980-index.html Edgar Link pending
0001477932-23-003980.txt Edgar Link pending
0001477932-23-003980-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trex_10q.htm Edgar Link pending
trex_ex311.htm Edgar Link pending
trex_ex321.htm Edgar Link pending
trxa-20230331.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
trxa-20230331_cal.xml Edgar Link unprocessable
trex_10q_htm.xml Edgar Link completed
trxa-20230331_lab.xml Edgar Link unprocessable
trxa-20230331_def.xml Edgar Link unprocessable
trxa-20230331_pre.xml Edgar Link unprocessable